Literature DB >> 28191690

Mutational profiling of acral melanomas in Korean populations.

Joon Ho Shim1,2, Hyun-Tae Shin2, Jiho Park3, Ji-Hye Park1, Jong-Hee Lee1,4, Jun-Mo Yang1, Duk-Hwan Kim5, Kee-Taek Jang6, Dong-Youn Lee1.   

Abstract

The proportion of acral melanoma (AM) is much higher in Asian populations than in Caucasian populations. Although mutational profiles associated with AM have been discovered in Caucasian populations, knowledge of its genetic alterations in Asian populations is limited. To describe the molecular nature of AM in Korean patients, we performed mutational profiling of AM and matched normal tissues in patients. Fifty-one formalin-fixed paraffin-embedded AM samples and 32 matched pairs from patients' saliva DNA were analysed by next-generation sequencing. Only mutations confirmed via digital droplet PCR or in BRAF, KIT and NRAS, the most frequently altered cancer genes in cutaneous melanoma, were considered as positive. The relationship between mutational status and clinicopathological features were examined. Of the 47 AM patients screened, alteration of BRAF, NRAS and KIT genes was observed in 6.4%, 4.3% and 8.5%, respectively. We also tested matched normal tissues of patients to identify tumor-specific mutations. Examination of the mutational profile in a cohort of 28 primary melanomas and matched normal controls found BRAF mutations in two cases (7.1%), KIT mutations in three cases (10.7%) and CTNNB1 mutations in one case (3.6%). The BRAF, NRAS and KIT mutation status did not correlate with clinicopathological characteristics. Our results show that KIT, NRAS and BRAF hotspot mutations occur at a low frequency in Korean populations. We also observed a case with the CTNNB1 mutation, which raises the possibility that other pathways are associated with AM development.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acral melanoma; mutational profile; next-generation sequencing; β-catenin gene

Mesh:

Substances:

Year:  2017        PMID: 28191690     DOI: 10.1111/exd.13321

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

1.  The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.

Authors:  Xiaoting Wei; Di Wu; Hang Li; Rui Zhang; Yu Chen; Hong Yao; Zhihong Chi; Xinan Sheng; Chuanliang Cui; Xue Bai; Zhonghui Qi; Ke Li; Shijie Lan; Lizhu Chen; Rui Guo; Xinyu Yao; Lili Mao; Bin Lian; Yan Kong; Jie Dai; Bixia Tang; Xieqiao Yan; Xuan Wang; Siming Li; Li Zhou; Charles M Balch; Lu Si; Jun Guo
Journal:  Ann Surg Oncol       Date:  2020-04-06       Impact factor: 5.344

2.  Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.

Authors:  Farshad Farshidfar; Kahn Rhrissorrakrai; Chaya Levovitz; Cong Peng; James Knight; Antonella Bacchiocchi; Juan Su; Mingzhu Yin; Mario Sznol; Stephan Ariyan; James Clune; Kelly Olino; Laxmi Parida; Joerg Nikolaus; Meiling Zhang; Shuang Zhao; Yan Wang; Gang Huang; Miaojian Wan; Xianan Li; Jian Cao; Qin Yan; Xiang Chen; Aaron M Newman; Ruth Halaban
Journal:  Nat Commun       Date:  2022-02-23       Impact factor: 17.694

3.  Systematic review and meta-analysis of genomic alterations in acral melanoma.

Authors:  Natasa Broit; Peter A Johansson; Chloe B Rodgers; Sebastian T Walpole; Nicholas K Hayward; Antonia L Pritchard
Journal:  Pigment Cell Melanoma Res       Date:  2022-03-07       Impact factor: 4.159

Review 4.  Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.

Authors:  Patricia Basurto-Lozada; Christian Molina-Aguilar; Carolina Castaneda-Garcia; Martha Estefania Vázquez-Cruz; Omar Isaac Garcia-Salinas; Alethia Álvarez-Cano; Héctor Martínez-Said; Rodrigo Roldán-Marín; David J Adams; Patricia A Possik; Carla Daniela Robles-Espinoza
Journal:  Pigment Cell Melanoma Res       Date:  2020-06-17       Impact factor: 4.693

Review 5.  More than just acral melanoma: the controversies of defining the disease.

Authors:  Sara S Bernardes; Ingrid Ferreira; David E Elder; Aretha B Nobre; Héctor Martínez-Said; David J Adams; Carla Daniela Robles-Espinoza; Patricia A Possik
Journal:  J Pathol Clin Res       Date:  2021-07-02

6.  Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival.

Authors:  Takamichi Ito; Yumiko Kaku-Ito; Maho Murata; Kazuhisa Furue; Che-Hung Shen; Yoshinao Oda; Masutaka Furue
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

7.  Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.

Authors:  Xiaoting Wei; Di Wu; Yu Chen; Hang Li; Rui Zhang; Hong Yao; Zhihong Chi; Chuanliang Cui; Xue Bai; Lili Mao; Zhonghui Qi; Ke Li; Shijie Lan; Lizhu Chen; Rui Guo; Xinyu Yao; Bin Lian; Yan Kong; Jie Dai; Bixia Tang; Xuan Wang; Jun Guo; Lu Si
Journal:  Br J Dermatol       Date:  2022-03-25       Impact factor: 11.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.